Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

BACKGROUND: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zi-Han, Fan, Ling, Yang, Jing, Huo, Xing-Yue, Guo, Yan, Zhang, Yi, Lan, Chun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683470/
https://www.ncbi.nlm.nih.gov/pubmed/31382897
http://dx.doi.org/10.1186/s12866-019-1558-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683470/
https://www.ncbi.nlm.nih.gov/pubmed/31382897
http://dx.doi.org/10.1186/s12866-019-1558-8

Ejemplares similares